Literature DB >> 15136629

Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.

Benjamin S Halpern1, Magnus Dahlbom, Andrew Quon, Christian Schiepers, Christian Waldherr, Daniel H Silverman, Osman Ratib, Johannes Czernin.   

Abstract

UNLABELLED: This study was performed to prospectively evaluate fast PET/CT imaging protocols using lutetium oxyorthosilicate (LSO) detector technology and 3-dimensional (3D) image-acquisition protocols.
METHODS: Fifty-seven consecutive patients (30 male, 27 female; mean age, 58.6 +/- 15.7 y) were enrolled in the study. After intravenous injection of 7.77 MBq (0.21 mCi) of (18)F-FDG per kilogram, a standard whole-body CT study (80-110 s) and PET emission scan were acquired for 4 min/bed position in 49 patients and 3 min/bed position in 8 patients. One-minute-per-bed-position data were then extracted from the 3- or 4-min/bed position scans to reconstruct single-minute/bed position scans for each patient. Patients were subgrouped according to weight as follows: <59 kg (<130 lb; n = 15), 59-81 kg (130-179 lb; n = 33), and >or=82 kg (>or=180 lb; n = 9). Three experienced observers recorded numbers and locations of lesion by consensus and independently rated image quality as good, moderate, poor, or nondiagnostic.
RESULTS: The observers analyzed 220 reconstructed whole-body PET images from 57 patients. They identified 114 lesions ranging in size from 0.7 to 7.0 cm on the 3- (n = 8) and 4-min/bed position images (n = 49). Of these, only 4 were missed on the 1-min/bed position scans, and all lesions were identified on the corresponding 2-min/bed position images. One- and 2-min/bed position image quality differed significantly from the 4-min/bed position image reference (P < 0.05).
CONCLUSION: LSO PET detector technology permits fast 3D imaging protocols whereby weight-based emission scan durations ranging from 1 to 3 min/bed position provide similar lesion detectability when compared with 4-min/bed position images.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136629

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.

Authors:  Martin A Lodge; Jeffrey P Leal; Arman Rahmim; John J Sunderland; Eric C Frey
Journal:  J Nucl Med       Date:  2018-06-14       Impact factor: 10.057

Review 2.  Dynamic whole-body PET imaging: principles, potentials and applications.

Authors:  Arman Rahmim; Martin A Lodge; Nicolas A Karakatsanis; Vladimir Y Panin; Yun Zhou; Alan McMillan; Steve Cho; Habib Zaidi; Michael E Casey; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

3.  Noise considerations for PET quantification using maximum and peak standardized uptake value.

Authors:  Martin A Lodge; Muhammad A Chaudhry; Richard L Wahl
Journal:  J Nucl Med       Date:  2012-05-24       Impact factor: 10.057

4.  PET/CT artifacts.

Authors:  Todd M Blodgett; Ajeet S Mehta; Amar S Mehta; Charles M Laymon; Jonathan Carney; David W Townsend
Journal:  Clin Imaging       Date:  2011 Jan-Feb       Impact factor: 1.605

5.  The clinical safety, biodistribution and internal radiation dosimetry of [¹⁸F]fluciclovine in healthy adult volunteers.

Authors:  Brian J McParland; Anders Wall; Silvia Johansson; Jens Sørensen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-24       Impact factor: 9.236

6.  FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas.

Authors:  Matthias R Benz; Johannes Czernin; William D Tap; Jeffrey J Eckardt; Leanne L Seeger; Martin S Allen-Auerbach; Sarah M Dry; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber
Journal:  Sarcoma       Date:  2010-04-18

7.  FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.

Authors:  Matthias R Benz; Johannes Czernin; Martin S Allen-Auerbach; William D Tap; Sarah M Dry; David Elashoff; Kira Chow; Vladimir Evilevitch; Jeff J Eckardt; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 8.  18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.

Authors:  Claudio Spick; Ken Herrmann; Johannes Czernin
Journal:  J Nucl Med       Date:  2016-01-07       Impact factor: 10.057

9.  Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.

Authors:  Matthias R Benz; Johannes Czernin; Sarah M Dry; William D Tap; Martin S Allen-Auerbach; David Elashoff; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

10.  The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.

Authors:  Martin Barrio; Johannes Czernin; Michael W Yeh; Miguel F Palma Diaz; Pawan Gupta; Martin Allen-Auerbach; Christiaan Schiepers; Ken Herrmann
Journal:  Nucl Med Commun       Date:  2016-12       Impact factor: 1.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.